Disease Activity-Associated Alteration of mRNA m5 C Methylation in CD4+ T Cells of Systemic Lupus Erythematosus

Gangqiang Guo, Huijing Wang, Xinyu Shi, Lele Ye, Kejing Yan, Zhiyuan Chen, Huidi Zhang, Zi‐Bing Jin, Xiangyang XueFrontiers in Cell and Developmental Biology 2020 · DOI

TL;DR

This study reveals that mRNA's 5-methylcytosine (m5C) modification patterns are significantly altered in CD4+ T cells of patients with Systemic Lupus Erythematosus (SLE), particularly correlating with disease activity. These alterations are linked to dysregulation of immune and inflammatory pathways, suggesting m5C methylation as a potential key player in SLE pathogenesis and a future therapeutic target.

What Problem Does This Paper Address?

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease where CD4+ T cells play a critical role. While epigenetic modifications like DNA methylation and histone modifications are known to contribute to SLE, the role of RNA modifications, specifically mRNA 5-methylcytosine (m5C) methylation, in CD4+ T cells of SLE patients has been largely unexplored. This paper aims to fill this knowledge gap by investigating how m5C methylation in CD4+ T cells is altered in SLE patients with varying disease activity and to understand the functional implications of these changes in the context of SLE pathogenesis.

Methods

The researchers employed a multi-omics approach to comprehensively analyze mRNA m5C methylation in CD4+ T cells. Key techniques included:

  • Liquid Chromatography-Coupled Triple Quadrupole Mass Spectrometry (LC-MS/MS): Used to quantify the levels of various mRNA modifications, including m5C, in pooled samples of CD4+ T cells from SLE patients (stable and moderate-to-major activity) and healthy controls (HCs).
  • RNA Sequencing (RNA-Seq): Performed to assess global mRNA gene expression profiles.
  • RNA Bisulfite Sequencing (RNA-Bis-Seq): Utilized to map the precise locations of m5C modifications across mRNA transcripts.
  • Bioinformatics Analysis: Integrated data from LC-MS/MS, RNA-Seq, and RNA-Bis-Seq to identify differentially methylated genes, analyze m5C site distribution, and perform pathway enrichment analysis.
  • Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) and Western Blot: Used to validate the expression levels of the key m5C methyltransferase, NSUN2, in CD4+ T cells from SLE patients and HCs.
  • Hypomethylated-mRNA Profiling: Analyzed in NSUN2-knockdown HeLa cells to understand the functional consequences of reduced NSUN2 activity.

Datasets

The study utilized samples from:

  • 47 subjects with SLE: Categorized into stable activity (SLEDAI < 5) and moderate-to-major activity (SLEDAI > 9) groups.
  • 46 age- and sex-matched healthy controls (HCs).

For specific analyses, samples were pooled:

  • LC-MS/MS, RNA-Seq, and RNA-Bis-Seq: 20 SLE patients and 18 HCs were divided into six groups (two pools per disease activity state/control group), with each pool comprising five or nine individuals.
  • qRT-PCR for NSUN2 expression: 45 subjects (22 SLE patients and 23 HCs).
  • Western blot for NSUN2 protein: 5 SLE patients and 5 HCs.

Key Insights and Ideas

  • m5C Methylation is Dysregulated in SLE CD4+ T Cells: The study provides strong evidence that m5C methylation patterns are significantly altered in CD4+ T cells from SLE patients compared to healthy individuals.
  • Disease Activity Matters: The degree of m5C alteration, particularly a decrease in overall m5C levels, correlates with increased disease activity in SLE patients. This suggests m5C modification could serve as a biomarker for disease severity.
  • NSUN2 is Downregulated in SLE: The primary mRNA m5C methyltransferase, NSUN2, shows significantly lower mRNA and protein expression in SLE CD4+ T cells, providing a potential molecular mechanism for the observed m5C dysregulation.
  • Functional Pathways are Affected: Genes with altered m5C methylation, especially hypermethylated ones, are heavily involved in critical immune and inflammatory pathways, including cytokine signaling and interferon signaling, directly implicating these modifications in SLE pathogenesis.
  • m5C Site Distribution is Conserved and Enriched: m5C sites are not randomly distributed but are conserved and enriched near translation initiation sites, suggesting a role in regulating gene expression at the post-transcriptional level.
  • Hypomethylation Links to Translation Elongation: Hypomethylated m5C genes in SLE and NSUN2-knockdown cells are linked to eukaryotic translation elongation and mRNA metabolism, hinting at broader impacts on cellular processes.

Key Results

  • Eleven mRNA modifications were detected, with elevated levels of Am, 3'OMeA, m1A, and m6A, and decreased levels of Ψ, m3C, m1G, m5U, and t6A in SLE CD4+ T cells.
  • Overall m5C levels were significantly lower in SLE CD4+ T cells compared to HCs, with a further decrease observed in patients with higher disease activity.
  • Despite lower overall m5C levels, the number of m5C-containing mRNAs was increased in SLE patients.
  • NSUN2 mRNA and protein expression were significantly reduced in SLE CD4+ T cells compared to HCs.
  • Pathway analysis revealed enrichment of immune-related and inflammatory pathways for hypermethylated m5C genes in SLE patients.
  • Hypomethylated m5C genes were significantly enriched in eukaryotic translation elongation and protein methylation pathways.

Limitations and Future Work

  • Sample Pooling: While necessary for obtaining sufficient material for multi-omics analysis, pooling samples from multiple individuals may mask subtle variations and requires careful interpretation. The authors acknowledge this by stating that "the number of CD4+ T cells able to be isolated from the peripheral blood is limited and patients with SLE exhibit heterogeneity."
  • Small Sample Size for Some Analyses: Specific analyses, like western blotting for NSUN2 protein, used a smaller number of samples.
  • Correlation vs. Causation: While strong associations are identified, further studies are needed to definitively establish causal relationships between m5C modifications, NSUN2 dysregulation, and SLE pathogenesis.
  • Unidentified Reader Proteins: The specific reader proteins that recognize the identified m5C motifs in SLE patients remain unknown and warrant further investigation.
  • Broader m5C Methyltransferases: The study focuses on NSUN2, but the authors speculate that other m5C methyltransferases might also be involved in SLE.
  • Future Directions: The authors suggest future research should focus on validating these findings in larger cohorts, exploring the precise mechanisms by which m5C modifications influence immune cell function in SLE, and investigating the potential of targeting m5C modifications as a therapeutic strategy for SLE. They also highlight the need for joint analysis of m6A and m5C modifications in the context of SLE.

Summary updated

Abstract

Epigenetic processes including RNA methylation, post-translational modifications, and non-coding RNA expression have been associated with the heritable risks of systemic lupus erythematosus (SLE). In this study, we aimed to explore the dysregulated expression of 5-methylcytosine (m<sup>5</sup>C) in CD4<sup>+</sup> T cells from patients with SLE and the potential function of affected mRNAs in SLE pathogenesis. mRNA methylation profiles were ascertained through chromatography-coupled triple quadrupole mass spectrometry in CD4<sup>+</sup> T cells from two pools of patients with SLE exhibiting stable activity, two pools with moderate-to-major activity, and two pools of healthy controls (HCs). Simultaneously, mRNA methylation profiles and expression profiling were performed using RNA-Bis-Seq and RNA-Seq, respectively. Integrated mRNA methylation and mRNA expression bioinformatics analysis was comprehensively performed. mRNA methyltransferase NSUN2 expression was validated in CD4<sup>+</sup> T cells from 27 patients with SLE and 28 HCs using real-time polymerase chain reaction and western blot analyses. Hypomethylated-mRNA profiles of NSUN2-knockdown HeLa cells and of CD4<sup>+</sup> T cells of patients with SLE were jointly analyzed using bioinformatics. Eleven methylation modifications (including elevated Am, 3'OMeA, m<sup>1</sup>A, and m<sup>6</sup>A and decreased Ψ, m<sup>3</sup>C, m<sup>1</sup>G, m<sup>5</sup>U, and t<sup>6</sup>A levels) were detected in CD4<sup>+</sup> T cells of patients with SLE. Additionally, decreased m<sup>5</sup>C levels, albeit increased number of m<sup>5</sup>C-containing mRNAs, were observed in CD4<sup>+</sup> T cells of patients with SLE compared with that in CD4<sup>+</sup> T cells of HCs. m<sup>5</sup>C site distribution in mRNA transcripts was highly conserved and enriched in mRNA translation initiation sites. In particular, hypermethylated m<sup>5</sup>C or/and significantly up-regulated genes in SLE were significantly involved in immune-related and inflammatory pathways, including immune system, cytokine signaling pathway, and interferon signaling. Compared to that in HCs, NSUN2 expression was significantly lower in SLE CD4<sup>+</sup> T cells. Notably, hypomethylated m<sup>5</sup>C genes in SLE and in NSUN2-knockdown HeLa cells revealed linkage between eukaryotic translation elongation and termination, and mRNA metabolism. Our study identified novel aberrant m<sup>5</sup>C mRNAs relevant to critical immune pathways in CD4<sup>+</sup> T cells from patients with SLE. These data provide valuable perspectives for future studies of the multifunctionality and post-transcriptional significance of mRNA m<sup>5</sup>C modification in SLE.
BibTeX
@inproceedings{guo2020disease,
  author = {Gangqiang Guo and Huijing Wang and Xinyu Shi and Lele Ye and Kejing Yan and Zhiyuan Chen and Huidi Zhang and Zi‐Bing Jin and Xiangyang Xue},
  title = {{Disease Activity-Associated Alteration of mRNA m5 C Methylation in CD4+ T Cells of Systemic Lupus Erythematosus}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2020},
  doi = {10.3389/fcell.2020.00430},
}
Figure